Shilpa Medicare Limited has informed the Exchange regarding a press release, titled "Press release on announcement of commissioning of a state-of-art Antibody Drug Conjugate (ADC) GMP Manufacturing Facility by Shilpa Biologicals Private Ltd, a material subsidiary of Shilpa Medicare Ltd.".
Shilpa Medicare Limited Press Release Jun 24 2026
Filed with NSE · · 3 pages · English
Release
Shilpa Medicare Limited on 6ix
Story so far
Earlier from Shilpa Medicare
- Press Release Jun 03 2026
- SteinCares and Shilpa Biologicals Strike into Licensing Agreement to Expand Access to Biosimilars Across Latin America
- Press Release Feb 24 2026
- Press Release Jan 28 2026
- Shilpa Pharma Lifesciences Awarded EcoVadis Gold Medal for Outstanding Sustainability Practices
Later from Shilpa Medicare
All Shilpa Medicare news releasesFollow Shilpa Medicare into a list and get an email when it puts out news.
Follow Shilpa Medicare